M
MAIA Biotechnology, Inc. (MAIA)
1.31
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
1.31
0.00 (0.00%)
MAIA Biotechnology, Inc. sho'ba korxonalari bilan birgalikda, immuno-onkologiya kompaniyasi bo'lib, saraton kasalligi bilan og'rigan insonlarning hayotini yaxshilash va uzaytirishga qaratilgan yangi ta'sir mexanizmlariga ega dorilarni ishlab chiqish va tijoratlashtirishga e'tibor qaratadi. Uning yetakchi dasturi THIO bo'lib, bu potentsial saratonni davolashda telomerlarga yo'naltirilgan vosita bo'lib, telomeraza-pozitiv saraton hujayralari bo'lgan NSCLC bemorlarini davolash uchun klinik rivojlanish bosqichida. Kompaniya 2018 yilda tashkil etilgan va shtab-kvartirasi Illinoys shtatining Chikago shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Sergei M. Gryaznov Ph.D. | Chief Scientific Officer |
| Linda Moreira | Company Secretary |
| Mr. Jeffrey C. Himmelreich | Head of Finance and Principal Financial & Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-04 | 8-K | form8-k.htm |
| 2026-01-20 | 8-K | form8-k.htm |
| 2026-01-13 | 8-K | form8-k.htm |
| 2026-01-05 | D | |
| 2025-12-17 | 8-K | form8-k.htm |
| 2025-12-11 | 8-K | form8-k.htm |
| 2025-12-10 | 8-K | form8-k.htm |
| 2025-11-21 | 8-K | form8-k.htm |
| 2025-11-20 | 8-K | form8-k.htm |
| 2025-11-07 | 10-Q | form10-q.htm |